Abstract View

Author(s): Ms. Vaishnavi D. Patil1, Ms. Sayali D. Patil2, Mr. Azam Z. Shaikh*3, Dr. S. P. Pawar4

Email(s): 1azamph46@gmail.com

Address:

    Department of Pharmaceutics P.S.G.V.P.M’s College of Pharmacy, Shahada

Published In:   Volume - 2,      Issue - 3,     Year - 2023

DOI: Not Available

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
Antibiotics are powerful medicines that treat certain infections and, when used correctly, can save lives. They either prevent the growth of bacteria or destroy them. Normally, the immune system can kill bacteria before they can multiply and cause symptoms. White blood cells (WBC) attack harmful bacteria. Even when symptoms appear, the immune system is usually able to manage and fight off the infection. However, there are times when the number of harmful bacteria is too large for the immune system to eliminate them all. Antibiotics can help in this scenario. The first antibiotic was penicillin. Penicillin-based antibiotics such as ampicillin, amoxicillin, and penicillin G are still available and have been used for many years to treat a variety of infections. There are several types of modern antibiotics that are usually available only by prescription in the United States. Topical antibiotics are available in over-the-counter (OTC) creams and ointments. Modern medicine has changed as a result of antibiotics. They facilitate critical therapies and procedures and are crucial for the treatment of infectious disorders. Nevertheless, despite their popularity, their continued usage in the twenty-first century is threatened by two unrelated problems. The first is that over time, the bacteria that these medications are meant to kill develop a tolerance to them. The second is that traditional mechanisms of payment are no longer cost-effective for discovering and developing antibiotics. As a result, there are fewer businesses and research facilities focused on producing new antibiotics, creating a pipeline that is anemic and endangers our ability to control diseases.

Cite this article:
Ms. Vaishnavi D. Patil, Ms. Sayali D. Patil, Mr. Azam Z. Shaikh, Dr. S. P. Pawar. A Review on Antibiotics as Drug and Poison. IJRPAS, March-April 2023; 2(2): 1-9


References not available.

Related Images:



Recent Images



Impaired Glucose Homeostasis During Clozapine Therapy in A Schizophrenic Patient: A Case Report
Development and Validation of an Eco-Friendly RP-HPLC Method for the Quantitative Estimation of Desidustat in Human Plasma
Personalized Pharmacotherapy in Obesity: Current Challenges, Emerging Therapeutic Algorithms, and Future Directions
Petrological Study on Sunstone: An Interdisciplinary Approach to Evaluate the Effect of Shodhana by Petrographic Thin Section Analysis
Gut Microbiota in Human Health And Disease: A Review of Therapeutic Opportunities.
Development and evaluation of Metformin Hydrochloride floating tablets using natural polymers with drug-polymer compatibility study by FTIR and analysis by UV spectrophotometer
Assessing Philippine Health Care Coverage Gaps: An Assessment of Accessibility of Public Health Programs in Selected Barangay in Imus, Cavite, Philippines
Isoabsorptive UV Spectrophotometry Method development and validation for simultaneous estimation of Eslicarbazepine Acetate and Carbamazepine
To develop and validate the stability indicating method for repaglinide and voglibose using HPLC method
To develop and validate the stability indicating method for Empagliflozin and Linagliptin using HPLC method

Tags